Cargando…
Genetic Background of Polycythemia Vera
Polycythemia vera belongs to myeloproliferative neoplasms, essentially by affecting the erythroblastic lineage. JAK2 alterations have emerged as major driver mutations triggering PV-phenotype with the V617F mutation detected in nearly 98% of cases. That’s why JAK2 targeting therapeutic strategies ha...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027017/ https://www.ncbi.nlm.nih.gov/pubmed/35456443 http://dx.doi.org/10.3390/genes13040637 |
_version_ | 1784691255082483712 |
---|---|
author | Regimbeau, Mathilde Mary, Romain Hermetet, François Girodon, François |
author_facet | Regimbeau, Mathilde Mary, Romain Hermetet, François Girodon, François |
author_sort | Regimbeau, Mathilde |
collection | PubMed |
description | Polycythemia vera belongs to myeloproliferative neoplasms, essentially by affecting the erythroblastic lineage. JAK2 alterations have emerged as major driver mutations triggering PV-phenotype with the V617F mutation detected in nearly 98% of cases. That’s why JAK2 targeting therapeutic strategies have rapidly emerged to counter the aggravation of the disease. Over decades of research, to go further in the understanding of the disease and its evolution, a wide panel of genetic alterations affecting multiple genes has been highlighted. These are mainly involved in alternative splicing, epigenetic, miRNA regulation, intracellular signaling, and transcription factors expression. If JAK2 mutation, irrespective of the nature of the alteration, is known to be a crucial event for the disease to initiate, additional mutations seem to be markers of progression and poor prognosis. These discoveries have helped to characterize the complex genomic landscape of PV, resulting in potentially new adapted therapeutic strategies for patients concerning all the genetic interferences. |
format | Online Article Text |
id | pubmed-9027017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90270172022-04-23 Genetic Background of Polycythemia Vera Regimbeau, Mathilde Mary, Romain Hermetet, François Girodon, François Genes (Basel) Review Polycythemia vera belongs to myeloproliferative neoplasms, essentially by affecting the erythroblastic lineage. JAK2 alterations have emerged as major driver mutations triggering PV-phenotype with the V617F mutation detected in nearly 98% of cases. That’s why JAK2 targeting therapeutic strategies have rapidly emerged to counter the aggravation of the disease. Over decades of research, to go further in the understanding of the disease and its evolution, a wide panel of genetic alterations affecting multiple genes has been highlighted. These are mainly involved in alternative splicing, epigenetic, miRNA regulation, intracellular signaling, and transcription factors expression. If JAK2 mutation, irrespective of the nature of the alteration, is known to be a crucial event for the disease to initiate, additional mutations seem to be markers of progression and poor prognosis. These discoveries have helped to characterize the complex genomic landscape of PV, resulting in potentially new adapted therapeutic strategies for patients concerning all the genetic interferences. MDPI 2022-04-02 /pmc/articles/PMC9027017/ /pubmed/35456443 http://dx.doi.org/10.3390/genes13040637 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Regimbeau, Mathilde Mary, Romain Hermetet, François Girodon, François Genetic Background of Polycythemia Vera |
title | Genetic Background of Polycythemia Vera |
title_full | Genetic Background of Polycythemia Vera |
title_fullStr | Genetic Background of Polycythemia Vera |
title_full_unstemmed | Genetic Background of Polycythemia Vera |
title_short | Genetic Background of Polycythemia Vera |
title_sort | genetic background of polycythemia vera |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027017/ https://www.ncbi.nlm.nih.gov/pubmed/35456443 http://dx.doi.org/10.3390/genes13040637 |
work_keys_str_mv | AT regimbeaumathilde geneticbackgroundofpolycythemiavera AT maryromain geneticbackgroundofpolycythemiavera AT hermetetfrancois geneticbackgroundofpolycythemiavera AT girodonfrancois geneticbackgroundofpolycythemiavera |